Bruno Mourvillier, MD (he/him/his)

Professor
University Hospital of Reims
Reims, Champagne-Ardenne, France

Medical school in Paris, French critical care physician, formerly associate professor in medical and infectious disease ICU at Bichat Claude Bernard hospital in Paris. Spent one year at Massachusetts General Hospital as visiting scientist. Now full professor, head of medical ICU in university hospital of Reims, france (champagne region), particularly involved in severe infectious diseases issues. Served as country coordinator of the presented study.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB1529 - Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab’s Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia

  Friday, October 21, 2022
  1:55 PM – 2:05 PM US ET